$CLLS

$1.12▲ +4.7% YTD

5 SEC 13D/G filings tracked · Last updated Nov 9, 2026

Filing History

News

CLLS ▲ +4.7% - Cellectis S.A.

CP $1.12▲ +4.7%Nov 9, 2026 · ThinkSabio Blog

$CLLS - Cellectis to Report Third Quarter Financial Results on November 12, 2026…

SEC 13D/G

CLLS - Cellectis S.A. - SEC Filing Update (09-NOV-2026) | ThinkSabio - Stocks Simplified

$1.12▼ -77.14%Nov 9, 2026 · ThinkSabio Blog

$CLLS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #CLLS Cellectis S.A. : $1.12 Sector: Healthcare | YTD: 🔽 -77.14%…

News

CLLS ▼ -1.0% - Cellectis S.A.

CP $0.97▲ -1.0%Oct 27, 2026 · ThinkSabio Blog

$CLLS - Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026…

News

CLLS ▼ -9.3% - Cellectis S.A.

CP $1.46▲ -9.3%Sep 16, 2026 · ThinkSabio Blog

$CLLS d/g Underweight @ Barclays pt 1.30…

News

CLLS ▼ -0.6% - Cellectis S.A.

CP $3.10▲ -0.6%Sep 14, 2026 · ThinkSabio Blog

$CLLS - Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company…